TELA Bio, Inc.
TELA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $86 | $151 | $187 | $185 |
| - Cash | $53 | $47 | $42 | $44 |
| + Debt | $42 | $41 | $40 | $31 |
| Enterprise Value | $75 | $146 | $185 | $173 |
| Revenue | $69 | $58 | $41 | $29 |
| % Growth | 18.6% | 41.1% | 40.6% | – |
| Gross Profit | $46 | $40 | $27 | $19 |
| % Margin | 67.1% | 68.6% | 65.3% | 63.9% |
| EBITDA | -$32 | -$41 | -$39 | -$29 |
| % Margin | -45.7% | -69.5% | -94.3% | -98.9% |
| Net Income | -$38 | -$47 | -$44 | -$33 |
| % Margin | -54.6% | -79.8% | -106.9% | -112.9% |
| EPS Diluted | -1.33 | -2.04 | -2.73 | -2.3 |
| % Growth | 34.8% | 25.3% | -18.7% | – |
| Operating Cash Flow | -$42 | -$41 | -$41 | -$30 |
| Capital Expenditures | -$1 | -$1 | -$2 | -$1 |
| Free Cash Flow | -$43 | -$41 | -$43 | -$31 |